Gold standard for osteoporosis diagnosis and monitoring — very low radiation, quick, and painless.
What Does DEXA Bone Density Scan Show?
DEXA measures bone mineral density (BMD) at the lumbar spine and proximal femur (hip) — the standard sites for osteoporosis diagnosis. Results are reported as T-score (comparison to peak bone density) and Z-score (age-matched comparison). T-score ≤ -2.5 = osteoporosis; between -1.0 and -2.5 = osteopenia.
About DEXA
⚠️ Very low ionizing radiation (much less than a chest X-ray)
DEXA (Dual-Energy X-ray Absorptiometry) uses two low-energy X-ray beams at different energy levels to calculate bone mineral density (BMD). By measuring differential absorption in bone versus soft tissue, the scanner produces a precise BMD value at the lumbar spine and proximal femur — the standard measurement sites for osteoporosis diagnosis.
Radiation & Safety: DEXA effective dose is typically 1–5 microsieverts, compared to approximately 100 microsieverts for a chest X-ray. Radiation risk is negligible and not a meaningful clinical concern.
When to Use DEXA — and When Not To
Choosing the right modality is one of the most impactful parts of the prior authorization process. Payers are more likely to approve a study when the chosen modality is clearly the most appropriate tool for the clinical question.
✓ DEXA is the right choice when…
Osteoporosis diagnosis: DEXA is the gold standard, providing T-scores and Z-scores that define osteopenia and osteoporosis by WHO criteria.
Treatment monitoring: serial DEXA directly measures whether bisphosphonate or other therapy is increasing bone density.
Fracture risk quantification: BMD values input to FRAX generate quantitative fracture probability estimates.
⚠ Consider a different modality when…
Bone quality and microarchitecture: DEXA measures density only; high-resolution peripheral QCT or bone biopsy needed for true microarchitectural assessment.
Existing vertebral fractures: lateral spine X-ray or vertebral fracture assessment (VFA) identifies compression fractures that independently elevate fracture risk.
Metabolic bone disease (Paget's, hyperparathyroidism): bone scan and biochemical markers provide additional information DEXA cannot.
Measures density only — not bone quality or microarchitecture
Degenerative spinal changes and aortic calcification can falsely elevate lumbar spine BMD
Scanner-specific — ideally monitor on the same machine over time
📋 Patient Preparation
No fasting required. Avoid calcium supplements for 24 hours beforehand. Remove metal from the scan area. Recent nuclear medicine or contrast studies can occasionally affect results.
Common Indications
Clinical scenarios in which DEXA Bone Density Scan is typically ordered:
Monitoring response to osteoporosis treatment (typically every 1–2 years)
Initiation or discontinuation of osteoporosis medications
Contrast Protocols
When to order each protocol for DEXA Bone Density Scan:
Standard ProtocolNo contrast or injection required.
Prior Authorization Overview
Typical requirement: Prior auth requirements vary. Screening DEXA for eligible patients (women ≥65, men ≥70, postmenopausal women with risk factors) is often covered as preventive care. Monitoring frequency (typically every 1–2 years) is the main prior auth consideration.
✓ Key Approval Criteria
Screening: document age and risk factors per USPSTF/NOF guidelines
Monitoring: document prior DEXA results and treatment being monitored
Frequency: most payers follow 1–2 year intervals; shorter intervals require documentation
Steroid-induced: document duration and dose of corticosteroid therapy
⚠ Common Denial Pitfalls
DEXA within 1 year of prior study without documented reason for early repeat
Not documenting clinical risk factors for non-age-based indications
Ordering appendicular DEXA (77081) when axial is the clinically appropriate standard
Coverage by Payer
Select your payer for specific prior authorization criteria and policy details.
For most people, every 2 years is the typical monitoring interval once you start osteoporosis treatment or have been diagnosed with osteopenia. If your bone density is normal and you're getting a baseline screening, your doctor may recommend repeating in 5–10 years unless your risk factors change. Your physician will determine the right interval based on your T-scores, treatment, and risk factors. Insurance typically covers every 2 years for monitoring established osteoporosis or treatment response, and less frequently for screening in lower-risk individuals.
For most people, every 2 years is the typical monitoring interval once you start osteoporosis treatment or have been diagnosed with osteopenia. If your bone density is normal and you're getting a baseline screening, your doctor may recommend repeating in 5–10 years unless your risk factors change. Your physician will determine the right interval based on your T-scores, treatment, and risk factors. Insurance typically covers every 2 years for monitoring established osteoporosis or treatment response, and less frequently for screening in lower-risk individuals.